TABLE 4

Scheme B: MRTcell as functions of CLint,sec, CLd1, CLd2, ka, and nonlinear metabolism (Km of 20 μM and Vmax of 10 nmol/min). Initial drug concentrations of 100 and 300 μM were used; eq. 2 was used to estimate the MRT.


Cln

CLint,sec

MRTcell (min) at ka = 1 min-1

MRTcell (min) at ka = 30 min-1
CLd1 = CLd2 (0.02 ml/min)
CLd1 = CLd2 (0.5 ml/min)
CLd1 = CLd2 (1 ml/min)
CLd1 = CLd2 (5 ml/min)
CLd1 = CLd2 (0.02 ml/min)
CLd1 = CLd2 (0.5 ml/min)
CLd1 = CLd2 (1 ml/min)
CLd1 = CLd2 (5 ml/min)
μM ml/min
Apical Administration
100 1 27.9* 16.5 15.8 15.4 75.1* 15.5* 14.2 13.3
100 5 26.8* 24.1 23.9 23.7 53.0* 15.5* 14.4 13.5
100 10 35.5* 34.0 33.9 33.8 43.3* 15.6* 14.6 13.8
300 1 57.3* 31.1 30.7 30.5 104* 29.6 29.1 28.7
300 5 45.9* 38.8 38.5 38.3 87.9* 29.8 29.3 29.0
300 10 52.5* 48.9 48.7 48.6 78.5* 30.0 29.5 29.3
Basolateral Administration
100 1 136 22.2 21.0 20.2 134 20.1 18.9 18.0
100 5 145 30.8 29.3 28.4 134 20.4 19.2 18.3
100 10 156 41.3 39.6 38.6 134 20.8 19.5 18.7
300 1 138 46.0 45.4 44.9 136 43.7 43.1 42.7
300 5 149 55.0 54.2 53.7 136 44.0 43.4 43.0
300
10
162
64.9
63.8
63.2
137
44.5
43.8
43.4
  • * Deviating trend: increasing values of CLint,sec failed to increase the MRT